PLEXI-T
Live / Applied — First extension granted (statement of use) (as of 08 Dec 2025)
What this means for you
Not registered yet, but its 19 Aug 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98705565
- Mark type
- Stylized text
- Filed
- 19 Aug 2024
- Published for opposition
- 06 May 2025
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for use in the treatment of cancer
- Class 042 — Scientific and technological services: Pharmaceutical research and development in the nature of T-cell therapy for the treatment of cancer; T-cell therapy, namely pharmaceutical and scientific research for the treatment of cancer
Owner
- TScan Therapeutics, Inc., Waltham, MA, US
- TScan Therapeutics, Inc., Waltham, MA, US
Prosecution history
- 09 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Dec 2025 — SOU EXTENSION 1 GRANTED
- 08 Dec 2025 — SOU EXTENSION 1 FILED
- 08 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 May 2025 — PUBLISHED FOR OPPOSITION
- 30 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Apr 2025 — NON-FINAL ACTION E-MAILED
- 01 Apr 2025 — NON-FINAL ACTION WRITTEN